Follow Us:
Indomethacin

Indocin

Indomethacin

Indomethacin is a medication used to relieve pain, inflammation and swelling associated with conditions such as rheumatoid arthritis, osteoarthritis, gout and ankylosing spondylitis. It belongs to the non-steroidal anti-inflammatory drug (NSAID) class. It works by inhibiting cyclooxygenase (COX-1 and COX-2) enzymes, thereby reducing prostaglandin production and decreasing pain and inflammation. It is also used to treat acute gout attacks and certain inflammatory conditions. Indomethacin is available in oral capsules, tablets, suppositories and injectable formulations. Common side effects include nausea, headache, dizziness, abdominal pain and heartburn; serious risks include gastrointestinal bleeding and kidney problems.

Dosage Form: Tablet
Dosage Strength:
CAS No.: 53-86-1
Status:
Manufacturer:
Group: Nonsteroidal Anti-Inflammatory Drugs (NSAIDs)
Sub Group: Non-selective COX inhibitors
Class: Indole derivatives

Uses of Indomethacin

Indomethacin was historically used as a respiratory medicine for the symptomatic management of certain respiratory conditions. Its former uses included:

  • Rheumatoid arthritis: Relief of joint pain, swelling, and inflammation.
  • Osteoarthritis: Management of pain and stiffness associated with degenerative joint disease.Ankylosing spondylitis: Reduction of inflammatory spinal pain and stiffness.
  • Acute gout: Indomethacin is used for the management of pain and inflammation during acute gout attacks.
  • Bursitis and tendinitis: Relief of pain and inflammation associated with selected soft-tissue disorders.
  • Musculoskeletal disorders: Management of back pain, joint inflammation, sprains, and other painful conditions.
  • Postoperative pain: Selected formulations may be used for short-term pain management.
  • Patent ductus arteriosus (PDA): Intravenous indomethacin is used in selected premature infants to promote closure of a patent ductus arteriosus under specialist neonatal supervision.

Contraindication of Indomethacin

Indomethacin was historically subject to specific precautions during administration to ensure patient safety. Its former precautions included:

  • Known hypersensitivity to the medicine, aspirin, or other NSAIDs.
  • Previous serious allergic reactions, including NSAID-induced asthma or anaphylaxis.
  • Active peptic ulcer disease or gastrointestinal bleeding.
  • Severe renal impairment or severe hepatic impairment.
  • Severe heart failure or certain serious cardiovascular conditions.
  • Active pathological bleeding or significant bleeding disorders.
  • History of serious NSAID-related gastrointestinal bleeding or perforation.
  • Perioperative pain management associated with coronary artery bypass graft (CABG) surgery.
  • Late pregnancy, particularly from 30 weeks onward.

Precautions for Indomethacin

Indomethacin was majorly subjected to specific precautions during administration to ensure patient safety. Its former precautions included:

  • Gastrointestinal complications: Indole derivatives may cause stomach irritation, peptic ulcers, gastrointestinal bleeding, and, rarely, perforation.
  • Kidney function: Use cautiously in patients with renal impairment, dehydration, or conditions associated with reduced renal blood flow.
  • Cardiovascular risk: Patients with hypertension, heart disease, previous stroke, or heart failure require careful assessment because NSAIDs may increase cardiovascular complications.
  • Central nervous system effects: Indomethacin may cause headache, dizziness, drowsiness, confusion, and, occasionally, other neurological or psychiatric symptoms.
  • Liver function: Some medicines may cause elevated liver enzymes or hepatic injury. Monitoring may be necessary during prolonged treatment.
  • Asthma and allergies: Patients with aspirin-sensitive asthma or previous NSAID-related allergic reactions should avoid these medicines unless medically advised.
  • Pregnancy: Avoid routine use from 20 weeks of pregnancy unless specifically advised by a healthcare professional. Use from 30 weeks onward is generally avoided.
  • Elderly patients: Older adults may be more susceptible to gastrointestinal bleeding, kidney injury, and neurological adverse effects.
  • Treatment duration: Use the lowest effective dose for the shortest appropriate period.

Drug Interactions for Indomethacin

Potential drug interactions were historically documented when Indomethacin was prescribed alongside certain medications. These included:

  • Anticoagulants: Warfarin and direct oral anticoagulants may increase the risk of gastrointestinal and other bleeding.
  • Antiplatelet medicines: Aspirin and clopidogrel may increase bleeding risk when combined with indole derivatives.
  • Corticosteroids: Prednisolone and other corticosteroids may increase the risk of gastrointestinal ulcers and bleeding.
  • ACE inhibitors and ARBs: Concurrent use may reduce blood-pressure control and increase the risk of kidney injury.
  • Diuretics: NSAIDs may reduce diuretic effectiveness and increase the risk of fluid retention and renal impairment.
  • Lithium: Indomethacin and other NSAIDs may increase lithium concentrations and the risk of toxicity.
  • Methotrexate: Concurrent use may reduce methotrexate clearance and increase the risk of toxicity.
  • Cyclosporine and tacrolimus: Combination may increase the risk of kidney damage.
  • Other NSAIDs: Combining indole derivatives with other NSAIDs may increase gastrointestinal, renal, and cardiovascular adverse effects.
  • Probenecid: May increase indomethacin exposure and require dose adjustment.

Frequently Asked Questions

The most frequently asked questions focus on import, export, documentations, and regulation for Indomethacin.

The Indomethacin is a pharmaceutical active pharmaceutical ingredient (API) used in manufacturing of Indomethacin.

: Provides active pharmaceutical ingredients (APIs), customized production, and OEM/ODM services with research and technical cooperation across Europe, the USA, and India via Primeera Healthcare.

  • Therapeutic Goods Administration (TGA):
  • US Food and Drug Administration (USFDA):
  • European Medicines Agency (EMA):
  • African Medicines Agency (AMA):
  • National Medical Products Administration (NMPA):
  • Central Drugs Standard Control Organization (CDSCO):

Primeera Healthcare Private Limited can provide import coordination and pharmaceutical documentation assistance for Indomethacin, subject to confirmation of its current regulatory status and eligibility for import into India.

Documentation Required for Indomethacin Import

The import of medicines into India is regulated by the Central Drugs Standard Control Organisation (CDSCO) under the Drugs and Cosmetics Act, 1940, and the Drugs and Cosmetics Rules, 1945. The regulatory requirements depend on whether the product is an active pharmaceutical ingredient (API), a finished formulation, or an unapproved medicine intended for an individual patient's treatment.

Import Regulations and dcoumentation for Indomethacin

  • Import Documentation Assistance:
    Support with organising commercial invoices, packing lists, manufacturer details, product specifications, certificates of analysis, and other relevant documents required for regulatory review and customs processing.

  • Regulatory Coordination:
    Assistance with identifying applicable CDSCO requirements, import authorisations, and documentation procedures, subject to the product's regulatory status and the proposed import route.
  • Shipping and Customs Coordination:
    Coordination with relevant logistics providers and customs professionals to organise shipment documentation and facilitate clearance where legally permitted.
  • Compliance Verification:
    Preliminary review of available product and shipment documentation to identify potential regulatory gaps before procurement or dispatch. Import arrangements will proceed only after the applicable permissions and restrictions have been verified.

Customs Clearance and Compliance Handling of Indomethacin Import

Primeera Healthcare Private Limited can provide import coordination and pharmaceutical documentation assistance for Indomethacin, subject to confirmation of its current regulatory status and eligibility for import into India.

Export Regulations and dcoumentation for Indomethacin

The export of Indomethacin from India is subject to applicable requirements under the Drugs and Cosmetics Act, 1940, the Drugs and Cosmetics Rules, 1945, and relevant export, customs, and destination-country regulations. Documentation requirements depend on whether the product is an active pharmaceutical ingredient (API), a finished pharmaceutical formulation, or a medicine intended for a specific market. Export eligibility and destination-country requirements must be verified before shipment.

Documentation Required for Indomethacin Emport

  • Export Documentation Assistance:
    Assistance with organising commercial invoices, packing lists, manufacturer details, Indomethacin specifications, certificates of analysis, and other supporting documents required for Indomethacin export and customs processing.
  • Regulatory Coordination:
    Support in identifying applicable country specific Indomethacin export requirements, relevant manufacturing and export authorisations, and destination-country registration or import approval requirements, subject to the Indomethacin regulatory status.
  • Shipping and Customs Coordination:
    Coordination with logistics providers, freight forwarders, and customs professionals to organise shipping documentation, export declarations, and customs clearance procedures where legally permitted.
  • Compliance Verification:
    Preliminary review of available Indomethacin documentation, labelling, Indomethacin manufacturing information, and destination-market requirements to identify potential regulatory gaps before dispatch. Export arrangements will proceed only after the applicable restrictions and authorisations have been verified.

Customs Clearance and Compliance Handling of Indomethacin Export

Primeera Healthcare Private Limited can provide pharmaceutical export documentation assistance, regulatory coordination, and shipping support for Indomethacin, subject to confirmation of its export eligibility under applicable Indian regulations and the import requirements of the destination country.

Product Export Support

If you have any questions or need any help, contact our Support Team. We will get in touch with you within 24 hours from Monday to Friday between 9:00 and 10:00 CET.